Anpario (LON:ANP) Price Target Raised to GBX 600

Anpario (LON:ANP) had its target price upped by Canaccord Genuity Group from GBX 570 to GBX 600 in a research report report published on Friday, Marketbeat.com reports. They currently have a buy rating on the stock.

Separately, Shore Capital Group reiterated a “house stock” rating on shares of Anpario in a research report on Monday, August 17th. One equities research analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of GBX 600.

Anpario Stock Performance

Shares of ANP opened at GBX 460 on Friday. Anpario has a fifty-two week low of GBX 391.11 and a fifty-two week high of GBX 580. The company has a market capitalization of £74.92 million, a PE ratio of 12.12 and a beta of 1.08. The stock has a fifty day moving average of GBX 528.04 and a two-hundred day moving average of GBX 515.31. The company has a debt-to-equity ratio of 0.60, a quick ratio of 5.16 and a current ratio of 6.29.

Anpario (LON:ANP) last posted its quarterly earnings data on Wednesday, September 9th. The company reported GBX 22.45 earnings per share (EPS) for the quarter. Anpario had a return on equity of 17.05% and a net margin of 14.53%. As a group, analysts forecast that Anpario will post 23.5757801 EPS for the current year.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.